PureTech Health (PRTC) Current Deferred Revenue (2019 - 2021)

Historic Current Deferred Revenue for PureTech Health (PRTC) over the last 3 years, with Q4 2021 value amounting to $65000.0.

  • PureTech Health's Current Deferred Revenue fell 9558.42% to $65000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $65000.0, marking a year-over-year decrease of 9558.42%. This contributed to the annual value of $65000.0 for FY2021, which is 9558.42% down from last year.
  • According to the latest figures from Q4 2021, PureTech Health's Current Deferred Revenue is $65000.0, which was down 9558.42% from $1.5 million recorded in Q4 2020.
  • In the past 5 years, PureTech Health's Current Deferred Revenue registered a high of $5.5 million during Q4 2019, and its lowest value of $65000.0 during Q4 2021.
  • In the last 3 years, PureTech Health's Current Deferred Revenue had a median value of $1.5 million in 2020 and averaged $2.3 million.
  • Per our database at Business Quant, PureTech Health's Current Deferred Revenue crashed by 7310.92% in 2020 and then tumbled by 9558.42% in 2021.
  • Over the past 3 years, PureTech Health's Current Deferred Revenue (Quarter) stood at $5.5 million in 2019, then crashed by 73.11% to $1.5 million in 2020, then crashed by 95.58% to $65000.0 in 2021.
  • Its last three reported values are $65000.0 in Q4 2021, $1.5 million for Q4 2020, and $5.5 million during Q4 2019.